文献速递心血管胸部CT

脂蛋白(a)与冠状动脉粥样硬化及心血管事件:SCAPIS队列

Association of Lipoprotein(a) With Coronary Atherosclerosis and Cardiovascular Events: Findings From the SCAPIS Cohort.
PubMed 文献 · JACC Cardiovasc Imaging · 2026-07-18

该研究基于瑞典SCAPIS人群队列,纳入28529名中年个体,其中25916人完成冠状动脉CT血管成像。中位随访7.8年,分析脂蛋白(a)与冠脉粥样硬化负荷及冠脉事件的关系。结果显示高脂蛋白(a)主要经增加动脉粥样硬化负荷升高冠脉事件风险。

要点

  • 高Lp(a)个体冠脉粥样硬化出现提前2至3年。
  • 高Lp(a)与严重/广泛冠脉粥样硬化相关,OR为1.38。
  • 高Lp(a)主要经更大粥样硬化负荷驱动冠脉事件风险。

核心结论

  • 脂蛋白(a)主要通过驱动更高的冠状动脉粥样硬化负荷增加冠脉事件风险。
  • 高脂蛋白(a)在人群中可解释约5%至10%的严重动脉粥样硬化负担。
  • 研究结果支持广泛检测脂蛋白(a)并对高值个体采用冠脉影像进行危险分层。

研究设计与样本

  • 基于瑞典SCAPIS人群队列的前瞻性研究。
  • 纳入28529名中年个体,其中25916人完成冠状动脉CT血管成像。
  • 中位随访7.8年,冠脉事件定义为致死或非致死性心肌梗死。
  • 高脂蛋白(a)定义为队列中的界值,占参与者14%。

关键影像表现/征象

  • 高脂蛋白(a)与严重/广泛冠状动脉粥样硬化相关,以节段受累评分>4为界值。
  • 经分层、校正及中介分析显示脂蛋白(a)与冠脉事件关联主要由粥样硬化负荷解释。
  • 高脂蛋白(a)个体出现动脉粥样硬化提前2至3年。

诊断标准与关键数值

  • 严重/广泛冠状动脉粥样硬化定义为节段受累评分>4。
  • 高脂蛋白(a)与严重/广泛冠脉粥样硬化的OR为1.38,95%CI为1.21-1.57。
  • 高脂蛋白(a)与冠脉事件风险的HR为1.54,95%CI为1.18-2.0。
  • 中介分析显示动脉粥样硬化负荷的解释具有统计学意义,P<0.0001。
  • 高脂蛋白(a)对严重动脉粥样硬化的群体归因分数为5%至10%。

临床应用与阅片要点

  • 冠脉CTA可用于高脂蛋白(a)个体的粥样硬化负荷评估与危险分层。
  • 阅片时高Lp(a)患者应重点关注冠脉节段受累评分和广泛钙化/斑块负荷。
  • 报告可提示高Lp(a)相关粥样硬化提前出现及更高总疾病负担。

局限性

  • 冠脉事件数量相对有限,影响效应估计精度。
  • 观察性设计存在残余混杂可能。
  • 未提供高脂蛋白(a)的具体临界值数值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: High lipoprotein(a) (Lp[a]) associates with elevated coronary heart disease event risk, but it remains uncertain whether this excess risk can be explained by increased coronary plaque burden.

OBJECTIVES: This study aims to determine whether Lp(a)-related excess cardiovascular risk in the general population is primarily explained by increased coronary atherosclerosis or by additional plaque vulnerability-related effects.

METHODS: This study included 28,529 middle-aged individuals from the SCAPIS (Swedish CArdioPulmonary bioImage Study), a population-based cohort. Coronary atherosclerosis was assessed using coronary computed tomography angiography in 25,916 participants. Incident coronary events, defined as fatal or nonfatal myocardial infarction, were ascertained over a median follow-up of 7.8 years.

RESULTS: High Lp(a) was present in 14% of participants and associated with severe/extensive coronary atherosclerosis (Segment Involvement Score >4; OR: 1.38; 95% CI: 1.21-1.57) and coronary events (HR: 1.54; 95% CI: 1.18-2.0). Stratified, adjusted, and mediation analyses consistently suggested that the association between Lp(a) and coronary event risk is largely explained by greater atherosclerotic burden (P for mediation <0.0001). Individuals with high Lp(a) developed atherosclerosis 2 to 3 years earlier and the population-attributable fraction of Lp(a) was 5% to 10% for severe atherosclerosis and around 7% for coronary events.

CONCLUSION: The findings suggest that Lp(a) increases coronary event risk primarily by driving a higher burden of atherosclerosis and that high Lp(a) accounts for 5% to 10% of total coronary disease burden in the population. These results support broad Lp(a) measurements and the use of coronary imaging for risk stratification in individuals with high Lp(a).

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Björnson, Bergström, Brinck, et al. Association of Lipoprotein(a) With Coronary Atherosclerosis and Cardiovascular Events: Findings From the SCAPIS Cohort. JACC Cardiovasc Imaging. 2026. PMID: 42470409. doi:10.1016/j.jcmg.2026.05.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。